D-2-hydroxyglutarate was also reported to inhibit the branched-chain amino acid aminotransferase (BCAT) transaminases and thus rendered gliomas cells addicted to glutamine and more sensitive to glutaminase inhibition (36, 43). This evidence concerns the gene GLS and central nervous system cancer.